Atorlip Gold Information
Atorlip Gold is an allopathic medicine The correct dosage of Atorlip Gold depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Atorlip Gold Benefits & Uses
Atorlip Gold is used to treat the following -
Main Benefits
- High Cholesterol (Read More - Home remedies for high cholesterol)
- Fever (Read More - Home remedies for fever)
- Heart Attack
Other Benefits
- High Triglycerides
- High Lipoprotein
- Heart Disease (Read More - Home remedies for heart disease)
- Homozygous Familial Hypercholesterolemia
- Joint Pain (Read More - How to Relieve Joint Pain Naturally: Best Home Remedies)
- Muscle Pain (Read More - Home Remedies for Muscle Aches)
- Rheumatoid Arthritis
- Osteoarthritis
- Blood Clotting Disorders
- Kawasaki Disease
- Leg Pain (Read More - Home remedies for leg pain and weakness)
- Migraine (Read More - Home remedies for migraines)
- Headache
- Heart Failure
- Stroke
- Peripheral Vascular Disease
Atorlip Gold Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Atorlip Gold Related Warnings
-
Is the use of Atorlip Gold safe for pregnant women?
Atorlip Gold can have harmful effects in pregnant women. If you experience any discomfort after using Atorlip Gold, then discontinue the use and take your doctor's advice.
-
Is the use of Atorlip Gold safe during breastfeeding?
Side effects of Atorlip Gold for breastfeeding are little to none, so you can take it without doctor's advice.
-
What is the effect of Atorlip Gold on the Kidneys?
Atorlip Gold has very mild side effects on the kidneys.
-
What is the effect of Atorlip Gold on the Liver?
The liver can be affected by Atorlip Gold. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Atorlip Gold only after medical advice.
-
What is the effect of Atorlip Gold on the Heart?
Atorlip Gold has very mild side effects on the heart.
Severe Interaction of Atorlip Gold with Other Drugs
Atorlip Gold should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
Atorlip Gold Contraindications
If you are suffering from any of the following diseases, you should not take Atorlip Gold unless your doctor advises you to do so -
- Hypothyroidism
- Liver Disease
- Kidney Disease
- Diabetes
- Alcoholism
- Trauma
- Allergy
- Bleeding
- Asthma
- Gout
- Reye's syndrome
- Peptic Ulcer
- Glucose-6-Phosphate Dehydrogenase Deficiency
- Liver Disease
- Kidney Disease
- Bleeding
- Trauma
- Peptic Ulcer
- Aplastic Anemia
- Infections
- Liver Disease
Frequently asked Questions about Atorlip Gold
-
Is this Atorlip Gold habit forming or addictive?
No, you will not get addicted to Atorlip Gold.
Atorlip Gold Interactions with Food and Alcohol
-
Interaction between Food and Atorlip Gold
Eating certain foods may increase the time it takes Atorlip Gold to have an effect. You should consult your doctor about it.
-
Interaction between Alcohol and Atorlip Gold
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Atorlip Gold.
See all substitutes for Atorlip Gold
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199